Skip to main content

Sarah Cohen, PhD, and Mohanish Deshmukh, PhD Featured for Innovative Microscopy Work

August 18, 2022

Sarah Cohen, PhD, and Mohanish Deshmukh, PhD, researchers in the UNC Department of Cell Biology and Physiology and the UNC Neuroscience Center, were featured scientists in a Chan Zuckerberg Initiative article on an innovative new resource helping scientists probe the genetics of neurodegenerative diseases.  Full article found here.

Maria Ortiz Named HHMI Fellow

July 28, 2022

Congratulations to Maria Ortiz who has been named an HHMI Fellow!!  Fifty-one graduate students and their advisers are joining the thriving community supported by the HHMI Gilliam Fellowships for Advanced Study. Full article found here.

Scientists Reveal Genetic Architecture Underlying Alcohol, Cigarette Abuse

July 19, 2022

UNC School of Medicine researchers led by Hyejung Won, PhD, used a new kind of computational tool to parse the complicated genetics that put some people at higher risk of becoming addicted to alcohol, cigarettes, and likely other substances of abuse. Full article can be found on the UNC Health and UNC School of Medicine … Read more

Adam Hantman Named Yang Scholar

July 8, 2022

We are thrilled to announce that Adam Hantman was selected as a 2021-2022 Yang Family Biomedical Scholar! Please see the full story in the link in Vital Signs Congratulations to Adam and his research team on this award.  We are so glad to have you back at UNC as part of our Neuroscience community.

Scientists Detect Common Fungicide in Pregnant Women and Children

May 16, 2022

UNC-Chapel Hill scientists led by Mark Zylka, PhD, found measurable levels of a biomarker for azoxystrobin in pregnant women and young kids, and investigated the fungicide’s ability to pass from mothers to embryos in utero in mice and during lactation. Full article can be found on the UNC Health and UNC School of Medicine Newsroom … Read more

A New Wave of Psychiatric Care

April 25, 2022

UNC-affiliated startup Pulvinar Neuro’s novel treatment for mental illness – a technology that uses closed-loop, non-invasive stimulation of brain waves – offers hope to a rising tide of patients and recently led to the company’s acquisition by medical device leader Electromedical Products International. Full article can be found here.